Apyx Medical Analyst Ratings
Apyx Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 161.78% | Stephens & Co. | $8 → $5 | Maintains | Overweight |
| 08/11/2023 | 135.6% | Piper Sandler | $4 → $4.5 | Maintains | Overweight |
| 07/14/2023 | 318.85% | Stephens & Co. | → $8 | Initiates Coverage On | → Overweight |
| 06/15/2023 | 371.2% | Lake Street | $6 → $9 | Maintains | Buy |
| 05/24/2023 | — | JMP Securities | Reiterates | → Market Perform | |
| 05/12/2023 | 214.14% | Lake Street | $5 → $6 | Maintains | Buy |
| 12/08/2022 | 161.78% | Lake Street | → $5 | Assumes | → Buy |
| 08/12/2022 | 528.27% | Piper Sandler | $6 → $12 | Maintains | Overweight |
| 07/19/2022 | 790.05% | Lake Street | $14 → $17 | Maintains | Buy |
| 05/20/2022 | 528.27% | Lake Street | → $12 | Initiates Coverage On | → Buy |
| 08/13/2021 | 632.98% | JMP Securities | $12 → $14 | Maintains | Market Outperform |
| 05/12/2020 | 161.78% | JMP Securities | $7 → $5 | Maintains | Market Outperform |
| 11/12/2019 | 423.56% | Piper Sandler | $8 → $10 | Maintains | Overweight |
| 04/02/2019 | 318.85% | JMP Securities | $12 → $8 | Maintains | Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/10/2023 | 161.78% | Stephens & Co. | 8 美元 → 5 美元 | 維護 | 超重 |
| 08/11/2023 | 135.6% | 派珀·桑德勒 | 4 美元 → 4.5 美元 | 維護 | 超重 |
| 07/14/2023 | 318.85% | Stephens & Co. | → 8 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 06/15/2023 | 371.2% | 湖街 | 6 美元 → 9 美元 | 維護 | 買 |
| 05/24/2023 | — | JMP 證券 | 重申 | → 市場表現 | |
| 05/12/2023 | 214.14% | 湖街 | 5 美元 → 6 美元 | 維護 | 買 |
| 2022 年 8 月 12 日 | 161.78% | 湖街 | → 5 美元 | 假設 | → 購買 |
| 2022 年 12 月 8 日 | 528.27% | 派珀·桑德勒 | 6 美元 → 12 美元 | 維護 | 超重 |
| 2022 年 7 月 19 日 | 790.05% | 湖街 | 14 美元 → 17 美元 | 維護 | 買 |
| 05/20/2022 | 528.27% | 湖街 | → 12 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 08/13/2021 | 632.98% | JMP 證券 | 12 美元 → 14 美元 | 維護 | 市場表現跑贏大盤 |
| 05/12/2020 | 161.78% | JMP 證券 | 7 美元 → 5 美元 | 維護 | 市場表現跑贏大盤 |
| 2019 年 12 月 11 日 | 423.56% | 派珀·桑德勒 | 8 美元 → 10 美元 | 維護 | 超重 |
| 04/02/2019 | 318.85% | JMP 證券 | 12 美元 → 8 美元 | 維護 | 市場表現跑贏大盤 |
What is the target price for Apyx Medical (APYX)?
Apyx Medical（APYX）的目標價格是多少？
The latest price target for Apyx Medical (NASDAQ: APYX) was reported by Stephens & Co. on November 10, 2023. The analyst firm set a price target for $5.00 expecting APYX to rise to within 12 months (a possible 161.78% upside). 7 analyst firms have reported ratings in the last year.
斯蒂芬斯公司於2023年11月10日公佈了Apyx Medical（納斯達克股票代碼：APYX）的最新目標股價。該分析公司將目標股價定爲5.00美元，預計APYX將在12個月內升至12個月內（可能上漲161.78％）。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Apyx Medical (APYX)?
分析師對Apyx Medical（APYX）的最新評級是多少？
The latest analyst rating for Apyx Medical (NASDAQ: APYX) was provided by Stephens & Co., and Apyx Medical maintained their overweight rating.
Stephens & Co. 對Apyx Medical（納斯達克股票代碼：APYX）的最新分析師評級由Stephens & Co. 提供，Apyx Medical維持增持評級。
When is the next analyst rating going to be posted or updated for Apyx Medical (APYX)?
Apyx Medical（APYX）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apyx Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apyx Medical was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Apyx Medical的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Apyx Medical的最新評級是在2023年11月10日公佈的，因此您應該預計下一個評級將在2024年11月10日左右公佈。
Is the Analyst Rating Apyx Medical (APYX) correct?
分析師對Apyx Medical（APYX）的評級正確嗎？
While ratings are subjective and will change, the latest Apyx Medical (APYX) rating was a maintained with a price target of $8.00 to $5.00. The current price Apyx Medical (APYX) is trading at is $1.91, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Apyx Medical（APYX）評級保持不變，目標股價爲8.00美元至5.00美元。Apyx Medical（APYX）目前的交易價格爲1.91美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。